CAM trends
This article was originally published in The Tan Sheet
Executive Summary
Almost 68% of 2,049 survey respondents reported lifetime use of at least one CAM therapy, with an average of 3.03 therapies per user, according to data published in the Aug. 21 Annals of Internal Medicine. Phone survey conducted between November 1997 and February 1998 by Ronald Kessler, PhD, et al., Harvard University, finds continued use of a specific therapy in the 12 months before interview was 47% among treatments begun five to 10 years prior to interview, 48.8% for therapies begun 11-20 years earlier, and 45.7% for therapies started more than 20 years before. Findings suggest "slightly fewer than half of lifetime users continued to use CAM therapies in any given year throughout their life course," researchers conclude. The study is part of a special series on CAM in Annals (1"The Tan Sheet" May 28, p. 8)
You may also be interested in...
Annals Of Internal Medicine CAM Series Debuting, Harvard's Eisenberg Says
An Annals of Internal Medicine series on complementary and alternative medicine will begin later this year, David Eisenberg, MD, Harvard Medical School, said May 17.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands